Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Stemline climbs as analyst forecasts $500M in sales for its most advanced cancer drug
Stemline climbs as analyst forecasts $500M in sales for its most advanced cancer drug
Stemline climbs as analyst forecasts $500M in sales for its most advanced cancer drug
Submitted by
admin
on August 29, 2013 - 5:09pm
Source:
Yahoo/AP
News Tags:
Stemline
SL-401
acute myeloid leukemia
BPDCN
Headline:
Stemline climbs as analyst forecasts $500M in sales for its most advanced cancer drug
Do Not Allow Advertisers to Use My Personal information
